|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-9-16
|
|
pubmed:abstractText |
New-onset diabetes mellitus (NODM) in renal transplant recipients is a complication associated with an increased long-term morbidity and mortality. However, classic sulphonylureas have not been studied in transplanted patients to date. The purpose of this study was to investigate the use of gliquidone in NODM after renal transplantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
26-32
|
|
pubmed:meshHeading |
pubmed-meshheading:18793545-Adult,
pubmed-meshheading:18793545-Aged,
pubmed-meshheading:18793545-Cohort Studies,
pubmed-meshheading:18793545-Databases, Factual,
pubmed-meshheading:18793545-Diabetes Mellitus,
pubmed-meshheading:18793545-Female,
pubmed-meshheading:18793545-Humans,
pubmed-meshheading:18793545-Hypoglycemic Agents,
pubmed-meshheading:18793545-Kidney Failure, Chronic,
pubmed-meshheading:18793545-Kidney Transplantation,
pubmed-meshheading:18793545-Male,
pubmed-meshheading:18793545-Middle Aged,
pubmed-meshheading:18793545-Retrospective Studies,
pubmed-meshheading:18793545-Sulfonylurea Compounds,
pubmed-meshheading:18793545-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Gliquidone therapy of new-onset diabetes mellitus after kidney transplantation.
|
|
pubmed:affiliation |
Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
